Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes.
暂无分享,去创建一个
Francesco Stellacci | Darrell J Irvine | D. Irvine | F. Stellacci | P. Atukorale | Y. Yang | A. Bekdemir | R. Carney | P. H. Silva | N. Watson | Ahmet Bekdemir | Nicki Watson | Randy P Carney | Yu-Sang Yang | Prabhani U Atukorale | Paulo J Silva
[1] Sung Tae Kim,et al. Gold nanoparticles for nucleic acid delivery. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[2] Prabhani U. Atukorale,et al. Effect of particle diameter and surface composition on the spontaneous fusion of monolayer-protected gold nanoparticles with lipid bilayers. , 2013, Nano letters.
[3] M. Maccarini,et al. Effect of functionalized gold nanoparticles on floating lipid bilayers. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[4] N. Malmstadt,et al. Deformation and poration of lipid bilayer membranes by cationic nanoparticles , 2013 .
[5] F. Stellacci,et al. Erythrocyte incubation as a method for free-dye presence determination in fluorescently labeled nanoparticles. , 2013, Molecular pharmaceutics.
[6] Fan Zhan,et al. Smart photothermal-triggered bilayer phase transition in AuNPs-liposomes to release drug. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[7] Deepak N. Kapoor,et al. Characterization and evaluation , 2013 .
[8] B. Korgel,et al. Chloroform-enhanced incorporation of hydrophobic gold nanocrystals into dioleoylphosphatidylcholine (DOPC) vesicle membranes. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[9] Erik C. Dreaden,et al. The Golden Age: Gold Nanoparticles for Biomedicine , 2012 .
[10] F. Stellacci,et al. Dynamic Cellular Uptake of Mixed-Monolayer Protected Nanoparticles , 2012, Biointerphases.
[11] D. Irvine,et al. Oligonucleotide delivery by cell-penetrating "striped" nanoparticles. , 2011, Angewandte Chemie.
[12] H. Azzazy,et al. Gold Nanoparticles in Biomedicine , 2011 .
[13] S. Singh,et al. Functionalized Gold Nanoparticles and Their Biomedical Applications , 2011, Nanomaterials.
[14] Brahim Lounis,et al. Direct investigation of intracellular presence of gold nanoparticles via photothermal heterodyne imaging. , 2011, ACS nano.
[15] I. Bernhardt,et al. Red Cell Membrane Transport in Health and Disease , 2010 .
[16] Jordi Arbiol,et al. Hydrophobic gold nanoparticle self-assembly with phosphatidylcholine lipid: membrane-loaded and janus vesicles. , 2010, Nano letters.
[17] Chad A. Mirkin,et al. Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.
[18] P. Vekilov,et al. Interactions of hemin with model erythrocyte membranes. , 2010, The journal of physical chemistry. B.
[19] Francesco Stellacci,et al. Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.
[20] Martin Lenz,et al. ATP-dependent mechanics of red blood cells , 2009, Proceedings of the National Academy of Sciences.
[21] N. Mohandas,et al. Red cell membrane: past, present, and future. , 2008, Blood.
[22] Francesco Stellacci,et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. , 2008, Nature materials.
[23] Kristen N. Duthie,et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. , 2008, Nano letters.
[24] M. Magnani,et al. Cell-based drug delivery. , 2008, Advanced drug delivery reviews.
[25] Francesco Stellacci,et al. Water-soluble amphiphilic gold nanoparticles with structured ligand shells. , 2008, Chemical communications.
[26] Seungpyo Hong,et al. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? , 2007, Accounts of chemical research.
[27] Mehrdad Hamidi,et al. Applications of carrier erythrocytes in delivery of biopharmaceuticals. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[28] Vladimir R Muzykantov,et al. The Glycocalyx Protects Erythrocyte-Bound Tissue-Type Plasminogen Activator from Enzymatic Inhibition , 2007, Journal of Pharmacology and Experimental Therapeutics.
[29] Sung-Hee Park,et al. Loading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluidities. , 2006, Colloids and surfaces. B, Biointerfaces.
[30] A. Andriulli,et al. Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients—A Pilot Uncontrolled Study , 2005, The American Journal of Gastroenterology.
[31] Sarah L Veatch,et al. Miscibility phase diagrams of giant vesicles containing sphingomyelin. , 2005, Physical review letters.
[32] N. Mohandas,et al. Modulation of Erythrocyte Membrane Mechanical Function by Protein 4.1 Phosphorylation* , 2005, Journal of Biological Chemistry.
[33] D. Holdstock. Past, present--and future? , 2005, Medicine, conflict, and survival.
[34] Gianluca Damonte,et al. Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients. , 2004, Blood cells, molecules & diseases.
[35] A. Palamara,et al. Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections. , 2003, The Journal of antimicrobial chemotherapy.
[36] M. Magnani,et al. Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. , 2003, Vaccine.
[37] T. Triglia,et al. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Magnani,et al. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. , 2002, Antiviral research.
[39] Laura Chiarantini,et al. Erythrocytes deliver Tat to interferon‐γ‐treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro , 2002, Journal of leukocyte biology.
[40] M. Hamidi,et al. Inhibition of serum angiotensin‐converting enzyme in rabbits after intravenous administration of enalaprilat‐loaded intact erythrocytes , 2001, The Journal of pharmacy and pharmacology.
[41] M. Magnani,et al. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus. , 2001, The Journal of antimicrobial chemotherapy.
[42] L Bigi,et al. Erythrocyte‐mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease , 2001, Biotechnology and applied biochemistry.
[43] M. Magnani,et al. New drug combinations for the treatment of murine AIDS and macrophage protection , 2001, European journal of clinical investigation.
[44] M. Rouini,et al. In Vitro Characterization of Human Intact Erythrocytes Loaded by Enalaprilat , 2001, Drug delivery.
[45] Deborah A. Brown,et al. Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts* , 2000, The Journal of Biological Chemistry.
[46] H. Tajerzadeh,et al. Evaluation of Hypotonic Preswelling Method for Encapsulation of Enalaprilat in Intact Human Erythrocytes , 2000, Drug development and industrial pharmacy.
[47] A. De Flora,et al. Heterodimer-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol. , 1999, AIDS research and human retroviruses.
[48] P. Somerharju,et al. Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Grimaldi,et al. Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency metabolism and activity against human immunodeficiency virus or herpes simplex virus. , 1997, Antiviral research.
[50] M. Bendinelli,et al. FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5'-triphosphate. , 1995, Veterinary immunology and immunopathology.
[51] Mathias Brust,et al. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system , 1994 .
[52] E. Evans,et al. Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. , 1994, Annual review of biophysics and biomolecular structure.
[53] Felix Franks,et al. In-Vitro Characterization of mCerulean3_mRuby3 as a Novel FRET Pair with Favorable Bleed-Through Characteristics , 2019, Biosensors.
[54] N. Jain,et al. Erythrocytes as carriers of primaquine-preparation: characterization and evaluation , 1992 .
[55] N. Jain,et al. Erythrocytes as carriers of metronidazole: In-vitro characterization , 1992 .
[56] Mitchel Dh,et al. Bioactivity of electric field-pulsed human recombinant interleukin-2 and its encapsulation into erythrocyte carriers. , 1990 .
[57] DH Mitchell,et al. Bioactivity of electric field‐pulsed human recombinant interleukin‐2 and its encapsulation into erythrocyte carriers , 1990, Biotechnology and applied biochemistry.
[58] G. Ihler,et al. Hypotonic hemolysis methods for entrapment of agents in resealed erythrocytes. , 1987, Methods in enzymology.
[59] J. Berman,et al. Antileishmanial activity of human red blood cells containing formycin A. , 1985, The Journal of infectious diseases.
[60] D. Lewis,et al. Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes. , 1985, Biochemical pharmacology.
[61] H. Eichler,et al. Release of vitamin B12 from carrier erythrocytes in vitro , 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.
[62] D. Lewis,et al. Encapsulation of drugs in intact erythrocytes: an intravenous delivery system. , 1983, Biochemical pharmacology.
[63] D. Lewis,et al. The use of corticosteroids encapsulated in erythrocytes in the treatment of adjuvant induced arthritis in the rat. , 1983, Biochemical pharmacology.
[64] J. Deloach,et al. Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside. , 1982, American journal of veterinary research.
[65] T. Tsong,et al. Survival of sucrose-loaded erythrocytes in the circulation , 1978, Nature.
[66] E. Lightfoot,et al. Asparaginase entrapped in red blood cells: action and survival. , 1976, Science.
[67] U. Zimmermann,et al. Enzyme loading of electrically homogeneous human red blood cell ghosts prepared by dielelctric breakdown. , 1976, Biochimica et biophysica acta.
[68] A. Lowenthal,et al. Use of enzyme-loaded erythrocytes in in-vitro correction of arginase-deficient erythrocytes in familial hyperargininemia. , 1976, Clinical chemistry.
[69] H. Hönigsmann,et al. Glycocalyx of epidermal cells in vitro: demonstration and enzymatic removal. , 1975, The Journal of investigative dermatology.
[70] R H Glew,et al. Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.